GHRP-2
The Balanced GH Releaser
A growth hormone releasing peptide offering potent GH release with moderate effects on appetite and cortisol, popular for body composition.
Research Compound
About GHRP-2
GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide that stimulates the pituitary gland to release growth hormone. It's considered a balanced choice among GHRPs—more potent than Ipamorelin but with fewer side effects than GHRP-6 or Hexarelin. GHRP-2 provides reliable GH pulses without the extreme hunger that GHRP-6 causes, making it popular for those focused on body recomposition. It works synergistically with GHRH analogs like CJC-1295 for amplified GH release.
Mechanism of Action
GHRP-2 binds to ghrelin receptors (GHS-R1a) in the pituitary gland and hypothalamus, triggering the release of growth hormone. It also has a mild effect on ghrelin release, increasing appetite moderately. GHRP-2 amplifies the natural GH pulse when combined with GHRH, creating a synergistic effect greater than either peptide alone. It also suppresses somatostatin, the hormone that inhibits GH release.
How GHRP-2 Works in Your Body:
- Target Receptors: GHRP-2 binds to specific receptors that trigger downstream signaling cascades related to its primary benefits.
- Physiological Response: The body responds by modulating natural processes—whether hormone release, tissue repair, or cellular signaling—without replacing endogenous function.
- Timeline: Effects typically begin within 1-2 weeks, with optimal results seen over the recommended protocol duration.
Dosing Protocol
Frequency
2-3 times daily
Timing
Morning, post-workout, and before bed
Duration
8-16 week cycles
Important Notes
100-300mcg per dose subcutaneously. Best results when combined with CJC-1295 or other GHRH. Take on empty stomach for optimal absorption. Less desensitization than Hexarelin.
Clinical Research
3 studies on GHRP-2
GH Response Study
GHRP-2 produced significant, dose-dependent GH release in both young and elderly subjects.
Journal of Clinical Endocrinology & Metabolism
Body Composition
12 weeks of GHRP-2 increased lean mass and decreased fat mass in obese subjects.
Hormone and Metabolic Research
Synergy with GHRH
Combined GHRP-2 and GHRH produced GH release 3-10 times greater than either alone.
Endocrine Reviews
Growth Hormone Peptides Compared
Compare mechanism of action, FDA status, and use cases for the most popular growth hormone releasing peptides.
| Peptide | FDA Status | Mechanism | GH Release | Side Effects | Best For | Details |
|---|---|---|---|---|---|---|
Tesamorelin FDA-Approved GHRH Analog | FDA Approved | Binds GHRH receptors on pituitary, stimulating natural GH synthesis and pulsatile release | strong | moderate | Those seeking FDA-approved option for visceral fat reduction with physician oversight | View |
Sermorelin The Gold Standard GHRH | Compounded | First 29 amino acids of GHRH, triggers natural pulsatile GH release during sleep | moderate | minimal | Beginners seeking gentle GH optimization with excellent safety profile | View |
CJC-1295 Extended-Release GHRH | Research | Modified GHRH with DAC for extended half-life, sustained GH elevation over days | strong | moderate | Those wanting less frequent dosing with sustained GH benefits | View |
Ipamorelin Clean GH Secretagogue | Research | Selective ghrelin receptor agonist, triggers GH pulse without affecting cortisol/prolactin | moderate | minimal | Those wanting clean GH elevation without hormonal disruption | View |
Tesamorelin
FDA-Approved GHRH Analog
GH Release
Side Effects
Primary Uses
Those seeking FDA-approved option for visceral fat reduction with physician oversight
Learn MoreSermorelin
The Gold Standard GHRH
GH Release
Side Effects
Primary Uses
Beginners seeking gentle GH optimization with excellent safety profile
Learn MoreCJC-1295
Extended-Release GHRH
GH Release
Side Effects
Primary Uses
Those wanting less frequent dosing with sustained GH benefits
Learn MoreIpamorelin
Clean GH Secretagogue
GH Release
Side Effects
Primary Uses
Those wanting clean GH elevation without hormonal disruption
Learn MoreFDA-Approved Option
Tesamorelin is the only FDA-approved GHRH analog, offering the highest level of regulatory oversight for visceral fat reduction.
Beginner-Friendly
Sermorelin and Ipamorelin offer excellent tolerability profiles, making them ideal starting points for GH optimization.
Synergistic Stacking
GHRH peptides (Sermorelin, CJC-1295) can be stacked with GHRPs (Ipamorelin) for enhanced, synergistic GH release.
GHRP-2 in Practice
Who GHRP-2 is for
Users seeking a strong GH pulse with less appetite stimulation than GHRP-6, typically as part of a sermorelin or CJC-1295 stack for body composition and recovery. Suits people who want measurable GH/IGF-1 elevation but find ipamorelin too mild.
Who should avoid it
Anyone with elevated baseline cortisol, prolactin issues, insulin resistance, or those wanting to avoid any appetite increase. Pregnancy and active malignancy are absolute contraindications.
Clinical Context
GHRP-2 (pralmorelin) is a synthetic ghrelin receptor agonist that triggers significant GH release, with potency between ipamorelin and hexarelin. It modestly raises cortisol and prolactin (less than hexarelin, more than ipamorelin) and increases hunger (less than GHRP-6). It is not FDA-approved in the US but is licensed in Japan as a diagnostic agent for GH deficiency. The standard protocol is 100-300 mcg subcutaneously, 2-3 times daily, ideally pre-bed and post-workout, often paired with a GHRH analog for synergistic pulsatile release.
Common Mistakes to Avoid
Skipping the GHRH partner
GHRP-2 alone gives a single-pathway pulse. Adding sermorelin or CJC-1295 (no DAC) at the same dose creates a synergistic GH release that's roughly 2-3x larger than either alone.
Using post-meal
Insulin blunts the GH response. Dose at least 90 minutes after a meal, or pre-meal with a 20-minute window before eating.
Long-term continuous use
Like all GHRPs, GHRP-2 desensitizes with continuous use. Cycle 8-12 weeks on, 4 weeks off.
Important Safety Information
Medical Disclaimer: The information provided about GHRP-2 is for educational purposes only and is not intended as medical advice. Always consult with a qualified healthcare provider before starting any new supplement or peptide protocol.
Research Status: While GHRP-2 has shown promising results in research studies, many peptides are still being studied and may not be approved by regulatory bodies like the FDA for specific uses. The research cited represents ongoing scientific investigation.
Individual Variation: Responses to peptides vary significantly between individuals. What works for one person may not work for another. Side effects, while generally mild, can occur and should be monitored closely.
Quality & Sourcing: If you choose to use peptides, ensure you obtain them from reputable, tested sources. Peptide quality, purity, and proper storage are critical for safety and efficacy.
Legal Considerations: Peptide regulations vary by country and jurisdiction. Some peptides may require a prescription or may have restrictions on their use. Research the laws in your area before obtaining or using peptides.